PH12018550151A1 - Nutritional compositions and their use - Google Patents
Nutritional compositions and their useInfo
- Publication number
- PH12018550151A1 PH12018550151A1 PH12018550151A PH12018550151A PH12018550151A1 PH 12018550151 A1 PH12018550151 A1 PH 12018550151A1 PH 12018550151 A PH12018550151 A PH 12018550151A PH 12018550151 A PH12018550151 A PH 12018550151A PH 12018550151 A1 PH12018550151 A1 PH 12018550151A1
- Authority
- PH
- Philippines
- Prior art keywords
- nutritional compositions
- support
- composition
- infants
- mammals
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention concerns a nutritional composition to support, to promote, support a health status characterized by optimal brain and cognitive functions' development and/or prevention of neurocognitive deficits. This composition is for use in mammals, preferably in humans, for example in infants.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662315187P | 2016-03-30 | 2016-03-30 | |
US201662315280P | 2016-03-30 | 2016-03-30 | |
US201662328047P | 2016-04-27 | 2016-04-27 | |
EP16169351 | 2016-05-12 | ||
PCT/EP2016/080792 WO2017167418A1 (en) | 2016-03-30 | 2016-12-13 | Nutritional compositions and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12018550151A1 true PH12018550151A1 (en) | 2019-03-25 |
Family
ID=65529106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12018550151A PH12018550151A1 (en) | 2016-03-30 | 2018-09-05 | Nutritional compositions and their use |
Country Status (4)
Country | Link |
---|---|
CL (1) | CL2018002483A1 (en) |
MX (1) | MX2018011335A (en) |
PH (1) | PH12018550151A1 (en) |
RU (1) | RU2018138024A (en) |
-
2016
- 2016-12-13 MX MX2018011335A patent/MX2018011335A/en unknown
- 2016-12-13 RU RU2018138024A patent/RU2018138024A/en unknown
-
2018
- 2018-08-31 CL CL2018002483A patent/CL2018002483A1/en unknown
- 2018-09-05 PH PH12018550151A patent/PH12018550151A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2018138024A (en) | 2020-04-30 |
CL2018002483A1 (en) | 2019-01-04 |
MX2018011335A (en) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020550839A1 (en) | Spray-dried sialyllactose | |
MX2018012655A (en) | Compounds and methods for treating neurological and cardiovascular conditions. | |
PH12015502788A1 (en) | Antibody formulations and methods | |
MX2017003966A (en) | Cleaning and/or treatment compositions comprising malodor reduction compositions. | |
PH12016501307B1 (en) | Compounds | |
TW201613880A (en) | Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole | |
WO2016100157A3 (en) | 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists | |
WO2016100162A3 (en) | 5,5-bicyclic oxazole orexin receptor antagonists | |
NZ730334A (en) | Substituted 2-azabicycles and their use as orexin receptor modulators | |
MY183291A (en) | Lactoferrin and brain health and development in infants | |
MX2019002924A (en) | Purified human milk oligosaccharides compositions. | |
EP4218736A3 (en) | Compositions comprising 15-hepe | |
TN2016000435A1 (en) | Novel macrocyclic compounds. | |
PH12019502469A1 (en) | Novel fragrance compositions and products with mood enhancing effects | |
PH12015502543B1 (en) | Anti-regurgitation composition maintaining gut motility | |
MX2021003515A (en) | Polymorphic compounds and uses thereof. | |
PH12019500535A1 (en) | 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof | |
ZA202001295B (en) | Thiazolopyridine derivatives as adenosine receptor antagonists | |
MX2018008643A (en) | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives. | |
MX2020006140A (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions. | |
MX2017013278A (en) | Osmanthus odorant. | |
PH12018550151A1 (en) | Nutritional compositions and their use | |
BR112018067926A2 (en) | nutritional compositions and their uses | |
MY182818A (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
MX2021004804A (en) | Novel organoleptic compounds. |